- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 14, 2025 | 5.56M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2024 | 5.32M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2024 | 5.2M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 4.23M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 3.77M sh |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | −$5.46M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | −$3.87M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $3.8M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $3.68M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $3.9M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $3.68M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $1.51M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $2.6M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $2.82M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $3.94M |
| Eps Diluted | Q2 2025 · Dec 31, 2024 | −$0.13 |
| Eps Diluted | Q2 2025 · Dec 31, 2024 | −$0.36 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.13 |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −$2.61 |
| Cost Of Revenue | Q2 2025 · Dec 31, 2024 | $0 |
| Cost Of Revenue | Q2 2025 · Dec 31, 2024 | $0 |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2023 | $1.17M |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2023 | $2.01M |
| Capex | Q2 2025 · Dec 31, 2023 | $1.74K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$2.3M |
| Net Income restated | Q2 2025 · Dec 31, 2023 | −$359.56K |
| Net Income restated | Q2 2025 · Dec 31, 2023 | −$9.44M |
| Operating Income restated | Q2 2025 · Dec 31, 2023 | −$335.68K |
| Operating Income restated | Q2 2025 · Dec 31, 2023 | −$9.39M |
| Revenue | Q2 2025 · Dec 31, 2023 | $1.73M |
| Revenue | Q2 2025 · Dec 31, 2023 | $2.79M |